We introduce Hasco-Lek products to foreign markets where they are sold under our own labels. Our products are delivered to even the most remote regions of the world, like Libya and Vietnam which makes Hasco-Lek a brand recognizable across 15 distribution markets. Company is planning to strengthen its position in EU markets by expanding presence of the most efficient drugs from the portfolio.
Using our proven formulas, we support our clients in establishing their new brands or expanding their current portfolio.
Manufacturing products under our customers’ brands, has been an opportunity for us to offer comprehensive support in the production of pharmaceuticals, food supplements and cosmetics and to set up really good relations with our business partners. We’ve also learnt a lot from this type of business and we’re always keen to offer tailored solutions to meet our clients’ requirements.
From our broad portfolio, we have selected a list of CTD dossier products that are up to date with European GMP requirements. We offer to license and supply our products with release by EU QP. Enabling our customers’ sustainable growth is key for our out-licensing operations & we are offering to co-create value together with them.
Apart from our own product development activities with our own resources, we are expanding our product portfolio through In-license, to deliver our customers new high-quality products, we invest in the acquisition of new dossiers.
https://www.raucon.com/euro-plx/euroPLX-82
https://www.raucon.com/euro-plx/euroPLX-81
https://www.cphi.com/europe/en/home.html
st. Żmigrodzka 242e
51-131 Wroclaw
Poland
st. Aleje Jerozolimskie 154
02-326 Warsaw
Poland
From the beginning of its activities, Hasco‑Lek has been open to setting long term business relations with companies seated in different countries. We’ve started developing trade relations with the partners closest to us in Europe, later to expand cooperation with companies from all the continents.
Shortly after establishing the first pharmaceutical production lines, HASCO-LEK started building a network of business relations with the companies from the neighboring countries. Products such as Aromatol, Rub‑Arom or Hydrogen peroxide were successfully exported to the Baltic States. Today, we are proud to embrace advanced cooperation models, partnering with major pharmaceutical companies from all over the world. Until now our products have been delivered to 48 countries. We are grateful to our business partners for their trust and keeping long term business relations, some of which date back over 20 years.
We introduce Hasco-Lek products to foreign markets where they are sold under our own labels. Our products are delivered to even the most remote regions of the world, like Libya and Vietnam which makes Hasco-Lek a brand recognizable across 15 distribution markets. Company is planning to strengthen its position in EU markets by expanding presence of the most efficient drugs from the portfolio.
Using our proven formulas, we support our clients in establishing their new brands or expanding their current portfolio.
Manufacturing products under our customers’ brands, has been an opportunity for us to offer comprehensive support in the production of pharmaceuticals, food supplements and cosmetics and to set up really good relations with our business partners. We’ve also learnt a lot from this type of business and we’re always keen to offer tailored solutions to meet our clients’ requirements.
From our broad portfolio, we have selected a list of CTD dossier products that are up to date with European GMP requirements. We offer to license and supply our products with release by EU QP. Enabling our customers’ sustainable growth is key for our out-licensing operations & we are offering to co-create value together with them.
Apart from our own product development activities with our own resources, we are expanding our product portfolio through In-license, to deliver our customers new high-quality products, we invest in the acquisition of new dossiers.
https://www.raucon.com/euro-plx/euroPLX-82
https://www.raucon.com/euro-plx/euroPLX-81
https://www.cphi.com/europe/en/home.html
st. Żmigrodzka 242e
51-131 Wroclaw
Poland
st. Aleje Jerozolimskie 154
02-326 Warsaw
Poland
export@hasco-lek.pl
license_dbd@hasco-lek.pl
Przedsiębiorstwo Produkcji
Farmaceutycznej
Hasco-Lek S.A.
st. Żmigrodzka 242e
51-131 Wroclaw
phone: (+48) 71 352 95 22
fax: (+48) 71 352 76 36
hasco@hasco-lek.pl
